Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections
Tuberculosis resistant cases have been estimated to grow every year. Besides <i>Mycobacterium tuberculosis</i>, other mycobacterial species are responsible for an increasing number of difficult-to-treat infections. To increase efficacy of pulmonary treatment of mycobacterial infections a...
Main Authors: | Irene Rossi, Francesca Buttini, Fabio Sonvico, Filippo Affaticati, Francesco Martinelli, Giannamaria Annunziato, Diana Machado, Miguel Viveiros, Marco Pieroni, Ruggero Bettini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/5/203 |
Similar Items
-
Inhaled Antibiotics for Mycobacterial Lung Disease
by: Brandon Banaschewski, et al.
Published: (2019-07-01) -
Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in Mycobacterium abscessus
by: Anandi Martin, et al.
Published: (2020-01-01) -
Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species
by: Julia Solnier, et al.
Published: (2020-02-01) -
Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
by: Barbara De Siena, et al.
Published: (2020-12-01) -
The Contribution of Efflux Pumps in <i>Mycobacterium abscessus</i> Complex Resistance to Clarithromycin
by: Júlia S. Vianna, et al.
Published: (2019-09-01)